Long-term Outcomes in Primary CNS Lymphoma After R-MVP and High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplant-Reference-Cited by-同舟云学术

Long-term Outcomes in Primary CNS Lymphoma After R-MVP and High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplant

Published:2023-08-15 Issue:7 Volume:101 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Therkelsen Kate Elizabeth¹,Schaff Lauren R.¹^ORCID,Nandakumar Subhiksha¹,Omuro Antonio M.P.¹,DeAngelis Lisa M.¹,Grommes Christian¹

Affiliation:

1. From the Department of Neurology and Neurological Sciences (K.E.T.), Stanford University School of Medicine, CA; Department of Neurology (L.R.S., L.M.D., C.G.), Memorial Sloan Kettering Cancer Center; Department of Neurology (L.R.S., L.M.D., C.G.), Weill Cornell Medical College; Human Oncology and Pathogenesis Program (S.N.), Memorial Sloan Kettering Cancer Center, New York; and Department of Neurology (A.M.P.O.), Yale School of Medicine, New Haven, CT.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000207490

Reference12 articles.

1. Primary CNS Lymphoma

2. Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors;Jahnke K;J Neurooncol.,2006

3. Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma

4. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma;Gavrilovic IT;J Clin Oncol.,2006

5. Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma;British Journal of Haematology;2024-08-05

2. Translation and validation of the Neurological Assessment in Neuro-Oncology scale to Brazilian Portuguese;Frontiers in Neurology;2024-06-25

3. Survival, neurocognitive function, and health-related quality of life outcomes after rituximab—methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study;Neuro-Oncology;2023-12-01